MedTrace Logo

DiaCon Overnight Closed-Loop Glucose Control Study

NCT01444443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-11-20

No results posted yet for this study

Summary

The objective of this in-clinic study is to test our closed-loop glucose control system in patients with type 1 diabetes.

Conditions

Interventions

DEVICE

Closed-loop control

Blood glucose controlled by algorithm

OTHER

Open-loop control

Blood glucose controlled by patient

Sponsors & Collaborators

  • Technical University of Denmark

    collaborator OTHER

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Signe Schmidt, MD · Hvidovre University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444443 on ClinicalTrials.gov